Shareholder information

• Share price increased in value by 19 percent
  
• Transformation completed
  
• Dividend: increased 50 percent to proposed EUR 1.80 per share

Akzo Nobel share price

In 2007, Akzo Nobel shares again performed well, increasing in value by 19 percent. Total Shareholder Return (TSR) for the full year, including dividend, was 21 percent and Akzo Nobel ranked #2 compared with its new peer group. Trading volumes of our common shares increased by 50 percent compared with previous years.

The Board of Management and the Supervisory Board are proposing a dividend of EUR 1.80, an increase of 50 percent compared with the dividend of the last five years, which was stable at EUR 1.20. It is the company’s policy to distribute at least 45 percent of net income before incidentals as dividend. In May 2007, Akzo Nobel launched its initial share buyback program of EUR 1.6 billion, which was concluded at the end of August.

The company attaches great value to maintaining an open dialog with the financial community in order to promote transparency. Management gave presentations at a number of industry conferences, as well as in meetings with investors and analysts.
In 2007, a lot of time was spent with investors in order to explain the rationale of the proposed acquisition of ICI. In October 2007, new targets were presented to the financial community at well attended analyst meetings in London and New York. An intention to return EUR 3 billion to shareholders upon completion of the Henkel on sale in 2008 was also presented.

In addition to the Annual General Meeting (AGM) in April, there was an Extraordinary General Meeting (EGM) in November 2007, where the acquisition of ICI was approved. At the meetings, 40 to 50 percent of the capital was represented.

In the Netherlands, Akzo Nobel uses the Shareholders’ Communication Channel to distribute the agenda of the AGM, and to allow shareholders who hold their shares through an associated bank, to participate in proxy voting at the AGM.

During 2007, the company decided to deregister and terminate the reporting obligations under the U.S. Securities Act of 1934, and to delist from the NASDAQ stock exchange. Akzo Nobel will continue to provide a high standard of corporate governance, information and disclosure in line with the standard the company set itself during 2006. Akzo Nobel has a sponsored level 1 ADR program and ADRs can be traded at the otcQX platform in the United States.

Akzo Nobel’s common shares are listed at Euronext Amsterdam. For the financial calendar and contact details with Investor Relations, reference is made here.

share information